Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-691-9 | CAS number: 109-65-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Read across to 1-bromopropane. Whole-body inhalation exposure of Crl:CD(SD)IGS BR rats and the resulting offspring to vapor concentrations of 1-Bromopropane (100, 250, 500 and 750 ppm [F0 only]) for 6 hours per day, 7 days per week for a minimum of 70 days prior to mating and continuing until euthanasia produced no post-exposure clinical observations different from the control group animals exposed to filtered air. There were no mortalities related to exposure in the F0 generation. One F1 male in the 500 ppm group was euthanised in extremis during the second week of exposure. Body weight data (parental and pup) were reduced in the 500 (F0, F1 and F2) and 750 ppm (F0) groups. No macroscopic or microscopic pathology in brain tissue was observed. Complete lack of offspring was observed at exposures to 750 ppm, and a statistically decreased number of offspring compared to the control group was observed at exposures to 500 ppm (both generations). Non-statistically significant reductions in the number of offspring were observed in 250 ppm group for both generations. Fertility indices were statistically significantly reduced for the F0 500 ppm group. Reductions (not statistically significant) were observed in the 100, 250 and 500 ppm F1 groups. Extended estrous cycle lengths and an increase in the number of animals for which estrous cycle length could not be determined were observed in the 250 (F1), 500 (F0 and F1) and 750 (F0) ppm groups. The number of days between pairing and coitus were increased in the 500 and 750 ppm F0 groups. Reductions in organ weights were observed in the ovaries (500 and 750 ppm group F0 females), epididymides in the 250 (F0), 500 (F0 and F1) and 750 (F0) ppm group males, prostate (250, 500 and 750 ppm group F0 males), seminal vesicles (500 and 750 ppm group F0 males), pituitary in the 500 (F1) and 750 (F0) ppm group males and spleen in the F2 male and female weanlings. Organ weight differences from the control group values were also observed in the thymus (increase), liver (increase) and brain (decrease) in some groups. Generally, absolute values were different in treated animals compared to the control group values, but not when weights were expressed relative to body weights. Absolute brain weights were in the expected range for age, sex and strain, and no clinical or microscopic changes were correlated with the weight differences. No pathology associated with the thymus weight increases, and increased lipid vacuolation and glycogen content of the liver was considered reversible, and not of biological significance. Spermatogenic endpoints were adversely affected in the 500 (F0 and F1) and 750 (F0) ppm group males. Microscopic findings were observed in the ovaries in the 500 (F0 and F1) and 750 (F0) ppm group females.
Link to relevant study records
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Read across to structural analogue.
- Justification for type of information:
- Please see attached justification for read across in Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3800 (Reproduction and Fertility Effects)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Remarks:
- Doses / Concentrations:
100, 250, 500 and 750 ppm
Basis:
nominal conc.
750 ppm not used for F1 generation. - Remarks:
- Doses / Concentrations:
99, 252, 505 and 750 ppm for the F0 generation
Basis:
analytical conc.
mean measured - Remarks:
- Doses / Concentrations:
100, 252 and 504 ppm for the F1 generation.
Basis:
analytical conc.
mean measured - Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight gain and food consumption/food efficiency
- Remarks on result:
- other: equates to NOEC value (503 mg/m3) NOEC value of 503 mg/m3)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Developmental effects
- Remarks on result:
- other: Generation: F1 and F2 (migrated information)
- Remarks:
- equates to NOEC value (503 mg/m3) NOEC value of 503 mg/m3
- Mortality / viability:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 100 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Reproductive effects
- Reproductive effects observed:
- not specified
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEC
- 503 mg/m³
- Study duration:
- subchronic
- Species:
- rat
Additional information
Toxicity to reproduction is assessed via the use of read across to the structural analogue n-propyl bromide (1 -bromopropane).
Only one of the four studies available for this endpoint identified a quantitative NOAEL value which provided clear evidence of impaired fertility as a result of exposure to n-propyl bromide. This was a reliable study conducted to GLP using standard test methods and as such this value has been used as the key value for effects on fertility.
Whole-body inhalation exposure of Crl:CD(SD)IGS BR rats and the resulting offspring to vapor concentrations of 1-Bromopropane (100, 250, 500 and 750 ppm [F0 only]) for 6 hours per day, 7 days per week for a minimum of 70 days prior to mating and continuing until euthanasia produced no post-exposure clinical observations different from the control group animals exposed to filtered air. There were no mortalities related to exposure in the F0 generation. One F1 male in the 500 ppm group was euthanised in extremis during the second week of exposure. Body weight data (parental and pup) were reduced in the 500 (F0, F1 and F2) and 750 ppm (F0) groups. No macroscopic or microscopic pathology in brain tissue was observed. Complete lack of offspring was observed at exposures to 750 ppm, and a statistically decreased number of offspring compared to the control group was observed at exposures to 500 ppm (both generations). Non-statistically significant reductions in the number of offspring were observed in 250 ppm group for both generations. Fertility indices were statistically significantly reduced for the F0 500 ppm group. Reductions (not statistically significant) were observed in the 100, 250 and 500 ppm F1 groups. Extended estrous cycle lengths and an increase in the number of animals for which estrous cycle length could not be determined were observed in the 250 (F1), 500 (F0 and F1) and 750 (F0) ppm groups. The number of days between pairing and coitus were increased in the 500 and 750 ppm F0 groups. Reductions in organ weights were observed in the ovaries (500 and 750 ppm group F0 females), epididymides in the 250 (F0), 500 (F0 and F1) and 750 (F0) ppm group males, prostate (250, 500 and 750 ppm group F0 males), seminal vesicles (500 and 750 ppm group F0 males), pituitary in the 500 (F1) and 750 (F0) ppm group males and spleen in the F2 male and female weanlings. Organ weight differences from the control group values were also observed in the thymus (increase), liver (increase) and brain (decrease) in some groups. Generally, absolute values were different in treated animals compared to the control group values, but not when weights were expressed relative to body weights. Absolute brain weights were in the expected range for age, sex and strain, and no clinical or microscopic changes were correlated with the weight differences. No pathology was associated with the thymus weight increases, and increased lipid vacuolation and glycogen content of the liver was considered reversible, and not of biological significance. Spermatogenic endpoints were adversely affected in the 500 (F0 and F1) and 750 (F0) ppm group males. Microscopic findings were observed in the ovaries in the 500 (F0 and F1) and 750 (F0) ppm group females.
Short description of key information:
All toxicity to reproduction studies performed on n-propyl bromide were conducted using the inhalation route of exposure as due to the physicochemical properties of the substance this is the most likely route of exposure.
Five studies were available for this endpoint:
Toxicity to reproduction.001: NOAEL: 100 ppm (equal to a NOAEC of 503 mg/m3)
Toxicity to reproduction.002: No definitive conclusion possible
Toxicity to reproduction.003: Study terminated early due to insufficient fertility.
Toxicity to reproduction.004: No quantitative value established. Study concluded that the substance is a potential reproductive toxicant to men.
Toxicity to reproduction.005: No quantitative value established. Activation of 1-bromopropane via CYP2E1 may contribute to the male reproductive toxicity.
Effects on developmental toxicity
Description of key information
All toxicity to reproduction studies performed on n-propyl bromide were conducted using the inhalation route of exposure as due to the physicochemical properties of the substance this is the most likely route of exposure.
Two studies were available for this endpoint:
Developmental toxicity / teratogenicity.001 (full study): NOEL: maternal toxicity and fetal toxicity: 100 ppm; teratogenicity: 996 ppm
Developmental toxicity / teratogenicity.002 (range finding study): NOEL: maternal toxicity: 100 ppm
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Additional information
Toxicity to reproduction is assessed via the use of read across to the structural analogue n-propyl bromide (1 -bromopropane).
The studies do provide suspicion of developmental toxicity as a result of exposure to n-propyl bromide. The lowest NOEL value established for the developmental toxicity of n-propyl bromide is 100 ppm (equal to 503 mg/m3).
Justification for classification or non-classification
Toxicity to reproduction is assessed via the use of read across to the structural analogue n-propyl bromide (1 -bromopropane).
Based upon the results of read across to the analogue, the substance does meet the criteria for classification as a substance that should be regarded as if it would impair fertility in humans. In addition, the substance also meets the criteria for classification as a substance that should be regarded as causing concern for humans owing to possible developmental toxic
As such the substance is classified as a Reproductive toxicant Category 1B on Annex VI of the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 by manner of read across.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.